10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline

C204H146N22O2Si2 — CID 158798738

IUPAC10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline
SMILESCC1(C)c2ccccc2N(c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c3cc(N4c5ccccc5C(C)(C)c5ccccc54)cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3c2)c2ccccc21.C[Si]1(C)c2ccccc2N(c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c3cc(N4c5ccccc5[Si](C)(C)c5ccccc54)cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3c2)c2ccccc21.c1ccc(-c2cc(-c3ccccc3)nc(-c3cc(N4c5ccccc5Oc5ccccc54)cc4c(-c5nc(-c6ccccc6)cc(-c6ccccc6)n5)cc(N5c6ccccc6Oc6ccccc65)cc34)n2)cc1
InChIInChI=1S/C70H52N8.C68H52N8Si2.C66H42N6O2/c1-69(2)55-33-17-21-37-59(55)77(60-38-22-18-34-56(60)69)49-41-51-52(53(43-49)67-73-63(45-25-9-5-10-26-45)71-64(74-67)46-27-11-6-12-28-46)42-50(78-61-39-23-19-35-57(61)70(3,4)58-36-20-24-40-62(58)78)44-54(51)68-75-65(47-29-13-7-14-30-47)72-66(76-68)48-31-15-8-16-32-48;1-77(2)59-37-21-17-33-55(59)75(56-34-18-22-38-60(56)77)49-41-51-52(53(43-49)67-71-63(45-25-9-5-10-26-45)69-64(72-67)46-27-11-6-12-28-46)42-50(76-57-35-19-23-39-61(57)78(3,4)62-40-24-20-36-58(62)76)44-54(51)68-73-65(47-29-13-7-14-30-47)70-66(74-68)48-31-15-8-16-32-48;1-5-21-43(22-6-1)53-41-54(44-23-7-2-8-24-44)68-65(67-53)51-39-47(71-57-29-13-17-33-61(57)73-62-34-18-14-30-58(62)71)38-50-49(51)37-48(72-59-31-15-19-35-63(59)74-64-36-20-16-32-60(64)72)40-52(50)66-69-55(45-25-9-3-10-26-45)42-56(70-66)46-27-11-4-12-28-46/h2*5-44H,1-4H3;1-42H
InChIKeyITEYNAHFGFFHGI-UHFFFAOYSA-N
MW2993.74 g/mol
LogP49.43
Rot. Bonds24

About 10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline

10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline (PubChem CID 158798738) has the molecular formula C204H146N22O2Si2 and a molecular weight of 2993.74 g/mol. Its IUPAC name is 10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline.

Molecular Properties

Compound Name10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline
PubChem CID158798738
Molecular FormulaC204H146N22O2Si2
Molecular Weight2993.74 g/mol
Exact Mass2991.15
IUPAC Name10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline
SMILESCC1(C)c2ccccc2N(c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c3cc(N4c5ccccc5C(C)(C)c5ccccc54)cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3c2)c2ccccc21.C[Si]1(C)c2ccccc2N(c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c3cc(N4c5ccccc5[Si](C)(C)c5ccccc54)cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3c2)c2ccccc21.c1ccc(-c2cc(-c3ccccc3)nc(-c3cc(N4c5ccccc5Oc5ccccc54)cc4c(-c5nc(-c6ccccc6)cc(-c6ccccc6)n5)cc(N5c6ccccc6Oc6ccccc65)cc34)n2)cc1
InChIInChI=1S/C70H52N8.C68H52N8Si2.C66H42N6O2/c1-69(2)55-33-17-21-37-59(55)77(60-38-22-18-34-56(60)69)49-41-51-52(53(43-49)67-73-63(45-25-9-5-10-26-45)71-64(74-67)46-27-11-6-12-28-46)42-50(78-61-39-23-19-35-57(61)70(3,4)58-36-20-24-40-62(58)78)44-54(51)68-75-65(47-29-13-7-14-30-47)72-66(76-68)48-31-15-8-16-32-48;1-77(2)59-37-21-17-33-55(59)75(56-34-18-22-38-60(56)77)49-41-51-52(53(43-49)67-71-63(45-25-9-5-10-26-45)69-64(72-67)46-27-11-6-12-28-46)42-50(76-57-35-19-23-39-61(57)78(3,4)62-40-24-20-36-58(62)76)44-54(51)68-73-65(47-29-13-7-14-30-47)70-66(74-68)48-31-15-8-16-32-48;1-5-21-43(22-6-1)53-41-54(44-23-7-2-8-24-44)68-65(67-53)51-39-47(71-57-29-13-17-33-61(57)73-62-34-18-14-30-58(62)71)38-50-49(51)37-48(72-59-31-15-19-35-63(59)74-64-36-20-16-32-60(64)72)40-52(50)66-69-55(45-25-9-3-10-26-45)42-56(70-66)46-27-11-4-12-28-46/h2*5-44H,1-4H3;1-42H
InChIKeyITEYNAHFGFFHGI-UHFFFAOYSA-N
XLogP49.43
TPSA244.14 Ų
H-Bond Donors
H-Bond Acceptors24
Rotatable Bonds24
Heavy Atoms230
Complexity—

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 5002993.74
LogP ≤ 549.43
H-Bond Donors ≤ 50
H-Bond Acceptors ≤ 1024

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'heavy_metal', 'substructure': 'N/A'}

Analyze 10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

10-[8-(2,6-diphenyl-4-pyridinyl)dibenzo-p-dioxin-2-yl]-9,9-dimethylacridine;10-[8-(4,6-diphenyl-1,3,5-triazin-2-yl)dibenzo-p-dioxin-2-yl]-9,9-dimethylacridine;5-[8-(4,6-diphenyl-1,3,5-triazin-2-yl)dibenzo-p-dioxin-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline;2-[8-(4,6-diphenyl-1,3,5-triazin-2-yl)dibenzo-p-dioxin-2-yl]-9,9-dimethyl-10-phenylacridine;10-[8-(4,6-diphenyl-1,3,5-triazin-2-yl)dibenzo-p-dioxin-2-yl]phenothiazine;10-[8-(4,6-diphenyl-1,3,5-triazin-2-yl)dibenzo-p-dioxin-2-yl]phenoxazine;3-[8-(4,6-diphenyl-1,3,5-triazin-2-yl)dibenzo-p-dioxin-2-yl]-10-phenylphenoxazine
CID 158258534
10-[4-[4,6-bis[4-(9,9-dimethylacridin-10-yl)phenyl]-1,3,5-triazin-2-yl]phenyl]phenoxazine
CID 118528556
10-[6-(2,6-diphenylpyrimidin-4-yl)-9,9-dimethylxanthen-3-yl]-9,9-dimethylacridine
CID 134579076
5-[4-[4-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-2-(2,6-diphenylpyrimidin-4-yl)phenyl]-3-(2,6-diphenylpyrimidin-4-yl)phenyl]-10,10-dimethylbenzo[b][1,4]benzazasiline
CID 140793735
3-[7-(4,6-diphenyl-1,3,5-triazin-2-yl)-9,9-dimethyl-10-phenylacridin-2-yl]-10-phenylphenoxazine
CID 134579019
10-[4-[4-[4-(9,9-dimethylacridin-10-yl)phenyl]-6-phenyl-1,3,5-triazin-2-yl]phenyl]phenoxazine;10-[4-[4-(4-phenothiazin-10-ylphenyl)-6-phenyl-1,3,5-triazin-2-yl]phenyl]phenoxazine;10-[3-phenothiazin-10-yl-5-(6-phenyl-2-pyridinyl)phenyl]phenothiazine
CID 158999619
10-[5-(9,9-dimethylacridin-10-yl)-3,7-bis(2,6-diphenylpyrimidin-4-yl)naphthalen-1-yl]-9,9-dimethylacridine
CID 129290633
10-[3-(9,9-dimethylacridin-10-yl)-5-[4-phenyl-6-(4-phenylphenyl)-1,3,5-triazin-2-yl]phenyl]-9,9-dimethylacridine
CID 118528452
10-[4-[4-[4-(9,9-dimethylacridin-10-yl)phenyl]-6-phenyl-1,3,5-triazin-2-yl]phenyl]-9,9-dimethylacridine
CID 118528442
2-[7-(2,6-diphenylpyrimidin-4-yl)-9,9-dimethylfluoren-2-yl]-9,9-dimethyl-10-phenylacridine
CID 71007179
5-[4-[4-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-2-(4-pyridin-2-yl-6-pyridin-3-yl-1,3,5-triazin-2-yl)phenyl]-3-(4-pyridin-2-yl-6-pyridin-3-yl-1,3,5-triazin-2-yl)phenyl]-10,10-dimethylbenzo[b][1,4]benzazasiline;10-[4-[4-phenoxazin-10-yl-2-(4-pyridin-2-yl-6-pyridin-3-ylpyrimidin-2-yl)phenyl]-3-(4-pyridin-2-yl-6-pyridin-3-ylpyrimidin-2-yl)phenyl]phenoxazine;5-phenyl-10-[4-[4-(10-phenylphenazin-5-yl)-2-(4-pyridin-2-yl-6-pyridin-3-yl-1,3,5-triazin-2-yl)phenyl]-3-(4-pyridin-2-yl-6-pyridin-3-yl-1,3,5-triazin-2-yl)phenyl]phenazine
CID 161045076
10-[3-(4,6-diphenylpyrimidin-2-yl)-5-phenoxazin-10-ylphenyl]phenoxazine;10-[3-phenoxazin-10-yl-5-[4-phenyl-6-(4-phenylphenyl)pyrimidin-2-yl]phenyl]phenoxazine;10-[4-[4-phenyl-6-(4-phenylphenyl)pyrimidin-2-yl]phenyl]phenoxazine
CID 159209827

Frequently Asked Questions

What is the IUPAC name of 10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline?
The IUPAC name of 10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline (CID 158798738) is 10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline.
What is the SMILES notation for 10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline?
The canonical SMILES for 10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline is CC1(C)c2ccccc2N(c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c3cc(N4c5ccccc5C(C)(C)c5ccccc54)cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3c2)c2ccccc21.C[Si]1(C)c2ccccc2N(c2cc(-c3nc(-c4ccccc4)nc(-c4ccccc4)n3)c3cc(N4c5ccccc5[Si](C)(C)c5ccccc54)cc(-c4nc(-c5ccccc5)nc(-c5ccccc5)n4)c3c2)c2ccccc21.c1ccc(-c2cc(-c3ccccc3)nc(-c3cc(N4c5ccccc5Oc5ccccc54)cc4c(-c5nc(-c6ccccc6)cc(-c6ccccc6)n5)cc(N5c6ccccc6Oc6ccccc65)cc34)n2)cc1.
What is the InChIKey of 10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline?
The InChIKey is ITEYNAHFGFFHGI-UHFFFAOYSA-N. The full InChI is InChI=1S/C70H52N8.C68H52N8Si2.C66H42N6O2/c1-69(2)55-33-17-21-37-59(55)77(60-38-22-18-34-56(60)69)49-41-51-52(53(43-49)67-73-63(45-25-9-5-10-26-45)71-64(74-67)46-27-11-6-12-28-46)42-50(78-61-39-23-19-35-57(61)70(3,4)58-36-20-24-40-62(58)78)44-54(51)68-75-65(47-29-13-7-14-30-47)72-66(76-68)48-31-15-8-16-32-48;1-77(2)59-37-21-17-33-55(59)75(56-34-18-22-38-60(56)77)49-41-51-52(53(43-49)67-71-63(45-25-9-5-10-26-45)69-64(72-67)46-27-11-6-12-28-46)42-50(76-57-35-19-23-39-61(57)78(3,4)62-40-24-20-36-58(62)76)44-54(51)68-73-65(47-29-13-7-14-30-47)70-66(74-68)48-31-15-8-16-32-48;1-5-21-43(22-6-1)53-41-54(44-23-7-2-8-24-44)68-65(67-53)51-39-47(71-57-29-13-17-33-61(57)73-62-34-18-14-30-58(62)71)38-50-49(51)37-48(72-59-31-15-19-35-63(59)74-64-36-20-16-32-60(64)72)40-52(50)66-69-55(45-25-9-3-10-26-45)42-56(70-66)46-27-11-4-12-28-46/h2*5-44H,1-4H3;1-42H.
What are the key properties of 10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline?
10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline has a molecular weight of 2993.74 g/mol, XLogP of 49.43, 24 rotatable bonds, 0 hydrogen bond donors, and 24 hydrogen bond acceptors.
Where does this data come from?
All data for 10-[4,8-bis(4,6-diphenylpyrimidin-2-yl)-6-phenoxazin-10-ylnaphthalen-2-yl]phenoxazine;10-[6-(9,9-dimethylacridin-10-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-9,9-dimethylacridine;5-[6-(10,10-dimethylbenzo[b][1,4]benzazasilin-5-yl)-4,8-bis(4,6-diphenyl-1,3,5-triazin-2-yl)naphthalen-2-yl]-10,10-dimethylbenzo[b][1,4]benzazasiline is sourced from PubChem (CID 158798738), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).